Bristol, United Kingdom

Christopher Kilbane

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christopher Kilbane

Introduction

Christopher Kilbane is a notable inventor based in Bristol, GB. He has made significant contributions to the field of drug delivery systems, holding a total of 2 patents. His work focuses on enhancing the efficiency and effectiveness of medical treatments through innovative devices.

Latest Patents

Kilbane's latest patents include a drug delivery device designed for the delivery of two medicaments. This device features a housing that retains both a primary and a secondary drug delivery assembly. The secondary assembly includes a dose setting mechanism with a biasing member that resets the mechanism during use. Additionally, an actuator is incorporated, which moves relative to the housing and engages with an actuation collar to facilitate the delivery process. Another significant patent is a diagnostic device that further showcases his expertise in medical technology.

Career Highlights

Throughout his career, Kilbane has worked with prominent companies in the pharmaceutical and diagnostics sectors. Notable employers include Roche Diagnostics Operations, Inc. and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has contributed to his innovative approach to drug delivery and diagnostics.

Collaborations

Kilbane has collaborated with talented professionals in his field, including Thomas Z. Harkin and Sebastian Liedtke. These partnerships have likely enriched his work and led to advancements in his projects.

Conclusion

Christopher Kilbane's contributions to the field of drug delivery and diagnostics are noteworthy. His innovative patents and collaborations reflect his commitment to improving medical technology. His work continues to influence the industry and enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…